Publications by authors named "Assama Elkady"
J Cancer Res Ther
February 2022
Article Synopsis
- The study investigates the chemoresistance of epithelial ovarian cancer (EOC) to cisplatin, focusing on the role of CXC chemokine receptor 4 (CXCR4) and replication timing regulatory factor 1 (RIF1).
- It examines the correlation between higher expressions of CXCR4 and RIF1 with reduced sensitivity to the chemotherapy and worse patient outcomes, including overall survival.
- The findings suggest that both CXCR4 and RIF1 are linked to poor prognostic features and chemoresistance, with CXCR4 being the stronger predictor of overall survival.
